VBI VACCINES INC (VBIV)

CA91822J2020 - Common Stock

0.5695  0 (-0.26%)

After market: 0.57 +0 (+0.09%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
630K
-40.57%		1.08M
71.43%		8.682M
703.89%		20.238M
133.10%		N/A
EBITDA
YoY % growth
-66.19M
-57.71%		-79.76M
-20.50%		-53.321M
33.15%		N/AN/AN/A
EBIT
YoY % growth
-68.03M
-55.96%		-81.82M
-20.27%		-55.311M
32.40%		-16.093M
70.91%
Operating Margin
-10,798.41%-7,575.93%-637.08%-79.52%N/A
EPS
YoY % growth
-0.27
-28.57%		-0.43
-59.26%		-9.29
-2,060.47%		-0.84
91.00%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.54
83.21%
Revenue
Q2Q % growth		2.909M
493.67%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-10.475M
46.31%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.01
87.50%		-0.220.2195.54%
Q3 2023
Q2Q % growth		 -1.01
-1,022.22%		-0.14-0.87-607.28%
Q2 2023
Q2Q % growth		 -5.05
-2,705.56%		-2.20-2.85-129.21%
Q1 2023
Q2Q % growth		 -3.22
-3,925.00%		-1.28-1.95-152.55%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 853K
194.14%		5.467M-4.614M-84.40%
Q3 2023
Q2Q % growth		 6.62M
1,968.75%		13.516M-6.896M-51.02%
Q2 2023
Q2Q % growth		 720K
105.71%		947.58K-227.58K-24.02%
Q1 2023
Q2Q % growth		 490K
276.92%		833.34K-343.34K-41.20%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-211.76% -211.76% 0% 0%
Revenue-56.63% -56.63% 0% 0%